首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
Verfahren zur Herstellung von zusammengesetzten Farbstoff- Partikeln
摘要
申请公布号
DE60223742(D1)
申请公布日期
2008.01.10
申请号
DE2002623742
申请日期
2002.03.19
申请人
EASTMAN KODAK CO.
发明人
WANG, XIAORU;WANG, YONGCAI;SCHOFIELD, EDWARD
分类号
C08F2/44;C08F292/00;C09D11/00;C09D17/00
主分类号
C08F2/44
代理机构
代理人
主权项
地址
您可能感兴趣的专利
COMPOSITIONS CONTAINING PROTEOLYTIC ENZYME AND METHODS FOR CONTACT LENS CLEANING BY USE OF THEM
USE OF TOPIRAMATE AND DERIVATIVES FOR MANUFACTURING MEDICAMENT USEFUL FOR TREATING SCHIZOPHRENIA
14ALPHA, 17BETA-BRIGED ESTRATRIENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND PROCESS FOR THEIR PREPARATION, INTERMEDIATES THEREOF
A METHOD OF PRODUCING SO2 SORBENT THAT IS SUITABLE FOR USE TO DESULFURIZE COMBUSTION GASES
DOSING APPARATUS FOR ANIMAL FEEDING ESPECIALLY FOR STABLING ANIMALS
PHARMACEUTICAL COMPOSITIONS CONTAINING ALDEHYD AND AN ALUMINIUM COMPOUND
MULTI-PLY CELLULOSIC PAPER PRODUCT
STAB AND BULLET PROOF PROTECTIVE CLOTHING
FLUID OSCILLATOR, PART DESIGNED TO BE INCORPORATED IN A FLUIDIC OSCILLATOR AND METHOD FOR MAKING SUCH A FLUIDIC OSCILLATOR
ELECTRONIC LOCK WITH MECHANICAL CLUTCH
COMBINED VACCINES COMPRISING HEPATITIS B SURFACE ANTIGEN AND OTHER ANTIGENS
SYSTEM AND METHOD FOR PERFORMING CREDIT CARD TRANSACTIONS
ANTIBODIES TO THE ED-B DOMAIN OF FIBRONECTIN, CONJUGATES CONTAINING THEM AND USE THEREFOR FOR DIAGNOSIS AND THERAPY OF TUMORS AND DISEASES ASSOCIATED WITH ANGIOGENESIS
TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING STEROID HORMONES AND CRYSTALLIZATION INHIBITORS
A safety device for a motor vehicle
QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56LCK TYROSINE KINASES, USE OF THEM FOR PRODUCING PHARMACEUTICAL COMPOSITIONS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CARBOXY SUBSTITUTED CARBOXAMIDE DERIVATIVES AND THEIR USE AS TACHYKININ RECEPTOR ANTAGONISTS
UNSATURATED ETHYLENE COPOLYMER AND METHOD FOR THE PREPARATION THEREOF
Roller vane pump
NOVEL INTERMEDIATES AND PROCESSES FOR THE PREPARATION OF OPTICALLY ACTIVE OCTANOIC ACID DERIVATIVES
